Clinical Trial: DLBS1033 as Adjunctive Therapy for Patients With Diabetic Neuropathy

U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07683598) titled 'DLBS1033 as Adjunctive Therapy for Patients With Diabetic Neuropathy' on June 18.

Brief Summary: This study will evaluate the effect of DLBS1033 as adjunctive therapy in patients with diabetic neuropathy. Diabetic neuropathy is a common complication of diabetes that can cause numbness, tingling, pain, impaired nerve function, and reduced quality of life.

Participants with diabetic neuropathy will be randomly assigned to receive either DLBS1033 plus standard therapy or placebo plus standard therapy. The study will assess changes in nerve conduction study parameters, Toronto Clinical Neuropathy Score, interleukin-8, Galectin-3, and qu...